Name: PULMATRIX INC (PULM) Stock
Brand: PULMATRIX INC
Rating: 4 (3 reviews)

PULM Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: Pulmatrix Inc.

Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets

3 months ago - By: Benzinga - Mentions: CDXS VSTM SNOA OVID ...

12 Health Care Stocks Moving In Wednesday's After-Market Session

3 months ago - By: The Motley Fool

Pulmatrix (PULM) Q2 Revenue Falls 100%

3 months ago - By: Pulmatrix Inc.

Pulmatrix Announces Second Quarter 2025 Financial Results and Divestment Plan for Inhalation Assets

4 months ago - By: Benzinga - Mentions: GNTA GOVX SNGX OGEN ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

6 months ago - By: Pulmatrix Inc.

Pulmatrix Announces First Quarter 2025 Financial Results and Divestment Plan for Assets

a year ago - By: BusinessInsider

PULM Stock Earnings: Pulmatrix Reported Results for Q2 2024

a year ago - By: InvestorPlace

PULM Stock Earnings: Pulmatrix Reported Results for Q2 2024

2 years ago - By: InvestorPlace

PULM Stock Earnings: Pulmatrix Reported Results for Q1 2024

6 months ago - By: Kahn Swick & Foti, LLC

PULMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pulmatrix, Inc. - PULM

8 months ago - By: Pulmatrix Inc.

Pulmatrix Announces Year-End and Fourth Quarter 2024 Financial Results and Divestment Plan for Assets

2 years ago - By: BusinessInsider

PULM Stock Earnings: Pulmatrix Beats EPS, Beats Revenue for Q4 2023

9 months ago - By: Halper Sadeh LLC

PULM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Pulmatrix, Inc. Is Fair to Shareholders

a year ago - By: Halper Sadeh LLC - Mentions: ROIC BERY

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ROIC, BERY, PULM on Behalf of Shareholders

a year ago - By: Halper Sadeh LLC - Mentions: ENTO

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM, LBRDA, ENTO, LLYVA on Behalf of Shareholders

a year ago - By: Kahn Swick & Foti, LLC

PULMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pulmatrix, Inc. - PULM

a year ago - By: Halper Sadeh LLC - Mentions: ENTO

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM and ENTO on Behalf of Shareholders

a year ago - By: Ademi LLP

Shareholder Alert: Ademi LLP investigates whether Pulmatrix, Inc. is obtaining a Fair Price for its Public Shareholders

a year ago - By: Brodsky & Smith LLC - Mentions: ENTO MNTX CHTR

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Entero Therapeutics, Inc. (Nasdaq - ENTO), Pulmatrix, Inc. (Nasdaq – PULM), Liberty Broadband Corporation (Nasdaq – LBRDA, LBRDK, LBRDP), Manitex International, Inc.

a year ago - By: Halper Sadeh LLC

PULM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Pulmatrix, Inc. Is Fair to Shareholders

a year ago - By: Pulmatrix Inc.

Pulmatrix Announces Third Quarter 2024 Financial Results and Provides Corporate Update

a year ago - By: Pulmatrix Inc.

Pulmatrix Announces Second Quarter 2024 Financial Results and Provides Corporate Update

a year ago - By: Pulmatrix Inc. - Mentions: MNKD

Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation

1 years ago - By: Pulmatrix Inc.

Pulmatrix Announces Peer-Reviewed Publication of Clinical Results for its Orally Inhaled DHE for Acute Migraine (PUR3100)

2 years ago - By: Pulmatrix Inc.

Pulmatrix Announces First Quarter 2024 Financial Results and Provides Corporate Update

2 years ago - By: InvestorPlace

PULM Stock Earnings: Pulmatrix Beats EPS, Beats Revenue for Q4 2023

2 years ago - By: Pulmatrix Inc.

Pulmatrix Announces Year-End and Q4 2023 Financial Results and Provides Corporate Update

2 years ago - By: Pulmatrix Inc.

Pulmatrix Announces Stopping the PUR1900 Phase 2B Study Patient Enrollment and Closing the Study, in Agreement With Partner Cipla, to Preserve Cash and Facilitate Pursuit of Strategic Alternatives

2 years ago - By: Pulmatrix Inc.

Pulmatrix Announces Third Quarter 2023 Financial Results and Provides Corporate Update

2 years ago - By: Pulmatrix, Inc.

Pulmatrix Announces FDA Acceptance of IND Application for PUR3100 to Treat Acute Migraine

2 years ago - By: Pulmatrix, Inc.

Pulmatrix Announces Publication on Physiologically Based Pharmacokinetic Modelling of Potential Drug-Drug Interactions with PUR1900, Orally Inhaled Itraconazole

PULMATRIX INC (PULM) Stock News

PULM Latest News, Press Relases and Analysis